An interventional study of PRJ-205 and Placebo in Healthy, sponsored by Bioiberica. Completed at 1 site in Spain. Open to male participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-12-01.
Sponsored by Bioiberica · Not applicable and Interventional
Compare a dietary supplement (PRJ-205) and placebo during 1 or 4 days on aerobic exercise performance, oxidative stress and muscle damage.
The hypothesis is that supplementation with PRJ-205 improve aerobic performance
Twenty young active males will be recruited and randomized to either placebo or PRJ-205. Subjects will take the designated treatment in an acute dosage and chronically, 4 days of treatment.
They will undergo 3 exercise tasks (before the administration of the product, 1.5h after the acute administration of the product and after 4 days of treatment). VO2max and anaerobic threshold will be measured during the tests. Blood samples will be taken to measure muscle damage and oxidative stress.
Bioiberica is the lead sponsor of 16 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Treated volunteers will be administered one dose of PRJ-205 1,5 hours before the exercise task for the acute testing and will be taking one dose per day of PRJ-205 for 4 days for the chronic testing.
Dietary Supplement: PRJ-205
Placebo volunteers will be administered one dose of placebo 1,5 hours before the exercise task for the acute testing and will be taking one dose per day of placebo for 4 days for the chronic testing.
Other: Placebo
1 sachet per day
1 sachet per day
Aerobic performance determined by VO2max
Time frame: 4 days
Pressure pain threshold of calf muscle
Measured pre- and post- exercise task
Time frame: 4 days
Serum markers of muscular damage
Measured from blood samples taken pre- and post- exercise task.
Time frame: 4 days
Oxidative stress parameters
Measured from blood samples taken pre- and post- exercise task.
Time frame: 4 days
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bioiberica